ReCode Therapeutics

1 follower


ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.

Industries

Employees

51-200

Links

Org chart

Shehnaaz Suliman

Collapse
David J Lockhart
President & Chief Scientific Officer
April Loui
SVP, Quality & CMC Regulatory Affairs
John G. Matthews
SVP, Clinical Development
Erica V. Jefferson
SVP, Corporate Affairs
Daniel Siegwart
Co-Founder
Eneda Hoxha
Vice President, Intellectual Property & Business Development
Heather Clark
Svp, CF Franchise Lead
Sakya Mohapatra
Senior Director, Formulation and Process Development
Teri Keffer
Head Of People
Ariel Kantor
Vice President, Business Development & Platform Strategy
Max Barker
SVP, Legal Affairs & Business Operations
Carol Wolf
Senior Director, Accounting & Assistant Controller